Peptide Injections AI
Ovagen peptide therapy
Tissue Repair & HealingEmerging Evidence

Ovagen Peptide Therapy

Benefits, Side Effects, Cost & Protocols

Ovagen (Glu-Asp-Leu) is a short bioregulatory peptide targeting gastrointestinal and hepatic tissue. It is studied for its potential to normalize digestive function, support liver health, and maintain GI tract integrity.

ByChris Riley(CFA)&Alex Evans, PharmD, MBA(PharmD, MBA)|Updated

Clinically Reviewed

Reviewed by Alex Evans, PharmD, MBA · Updated May 2026

Evidence-Based

Sourced from FDA, PubMed & ClinicalTrials.gov · View sources

FDA Status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Emerging Evidence
Category
Tissue Repair & Healing

How Ovagen Works

Short peptide bioregulator that may modulate gene expression in hepatocytes and GI epithelial cells, supporting tissue maintenance and metabolic function.

Ovagen FAQ

What is OVAGEN?

Ovagen is a Khavinson bioregulator tripeptide researched for liver and gastrointestinal tissue support, particularly hepatic cell function and GI mucosal health.

How does OVAGEN work?

Short peptide bioregulator that may modulate gene expression in hepatocytes and GI epithelial cells, supporting tissue maintenance and metabolic function.

Is OVAGEN legal to buy?

OVAGEN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy OVAGEN?

OVAGEN is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does OVAGEN belong to?

OVAGEN is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.

What are the research benefits of OVAGEN?

OVAGEN has been studied for: Liver tissue support, GI mucosal health, Hepatic function, Digestive tissue repair. Khavinson bioregulator; liver and GI tissue focus.

Key Studies

34 total on PubMed8 human trials

Plasma inhibin A determination at start superovulatory FSH treatments is predictive for embryo outcome in goats

Gonzalez-Bulnes A, Garcia-Garcia RM, Carrizosa JA et al

Domest Anim Endocrinol · Domest Anim Endocrinol

Plasma inhibin A at FSH treatment start predicts embryo outcome in goats

Transvaginal follicular aspiration and embryo development in superstimulated early postpartum beef cows and subsequent fertility after artificial insemination

Aller JF, Mucci NC, Kaiser GG et al

Anim Reprod Sci · Anim Reprod SciAnimal

Transvaginal follicular aspiration in postpartum beef cows enables embryo development and maintains fertility after artificial insemination

Effects of low-dose follicle-stimulating hormone administration on follicular dynamics and preovulatory follicle characteristics in dairy cows during the summer

Friedman E, Glick G, Lavon Y et al

Domest Anim Endocrinol · Domest Anim EndocrinolAnimal

Low-dose FSH administration affects follicular dynamics and preovulatory follicle characteristics in dairy cows during summer

Effects of ovum pick-up frequency and FSH stimulation: a retrospective study on seven years of beef cattle in vitro embryo production

Ovagen News

News aggregated via Google News. Inclusion does not imply endorsement.

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies have not been evaluated by the FDA for most listed indications.All prices shown are estimates based on publicly available data and may not reflect current pricing — providers and brands set their own prices and can change them at any time. Always verify pricing directly with the provider before purchasing. Consult a licensed healthcare provider before starting any peptide protocol.

Ready to explore Ovagen with a provider?

Take our 2-minute quiz to get matched with a board-certified provider specializing in Ovagen.

Take the Quiz →